KNect365 Life Sciences is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Next Generation Therapeutics

REPORT: Emerging Technologies and Novel Approaches in Antibody Engineering and Therapeutics

ArticleImage

Download the data report

The Antibody Engineering & Therapeutics conference series recently (Aug 2019) conducted a survey of industry professionals from pharma, biotechs, academia, CDMOs, CROs, service providers and consultancies around the world. This report based on 211 responses reveals unique insights into the hottest potential opportunities and the biggest challenges around emerging technologies and novel approaches in antibody engineering and therapeutics. Dan Stanton, Editor of BioProcess Insider, introduces the report with what some of the key takeaways mean for the industry.

To download the exclusive report simply log in or register for a KNect365 account, which will give you access to all our exclusive premium content. 

Have any questions about the report or interested in sponsoring a future survey? Email andrew.burrows@knect365.com.

Emerging Tech in Antibody Therapeutics

Create your KNect365 account

Access this and more industry news, views, and keynotes from influencers and market movers.
You may be interested in attending our "Antibody Engineering & Therapeutics" event.
Please select if you'd like more information on:
Show
Please tick these boxes if you do not wish to receive marketing information relevant to you from KNect365 Life Sciences:
By creating an account you agree to Informa's Terms of Use and Privacy Policy